Preface—References

Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli, S., et al. 2004. A physical and functional map of the human TNF-αNF-κB signal transduction pathway. Nat. Cell Biol. 6: 97–105.

Chellappan S.P., Hiebert S., Mudryj M., Horowitz J.M., and Nevins J.R. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053–1061.

Helin K., Lees J.A., Vidal M., Dyson N., Harlow E., and Fattaey A. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70: 337–350.

Ho Y., Gruhler A., Heilbut A., Bader G.D., Moore L., Adams S.L., Millar A., Taylor P., Bennett K., Boutilier K., et al. 2002. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415: 180–183.

Kaelin W.G., Jr., Krek W., Sellers W.R., DeCaprio J.A., Ajchenbaum F., Fuchs C.S., Chittenden T., Li Y., Farnham P.J., Blanar M. A., et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70: 351–364.

Koh J., Enders G.H., Dynlacht B.D., and Harlow E. 1995. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506–510.

Lee I., Date S.V., Adai A.T., and Marcotte E.M. 2004. A probabilistic functional network of yeast genes. Science 306: 1555–1558.

Lukas J., Parry D., Aagaard L., Mann D.J., Bartkova J., Strauss M., Peters G., and Bartek J. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375: 503–506.

Lyapina S., Cope G., Shevchenko A., Serino G., Tsuge T., Zhou C., Wolf D.A., Wei N., and Deshaies R.J. 2001. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292: 1382–1385.

Pickford A.R., and Campbell I.D. 2004. NMR studies of modular protein structures and their interactions. Chem. Rev. 104: 3557–3566.

Ranade K., Hussussian C.J., Sikorski R.S., Varmus H.E., Goldstein A.M., Tucker M.A., Serrano M., Hannon G.J., Beach D., and Dracopoli N.C. 1995. Mutations associated with familial melanoma impair p16INK4 function. Nat. Genet. 10: 114–116.

Reymond A. and Brent R. 1995. p16 proteins from melanoma-prone families are deficient in binding to Cdk4. Oncogene 11: 1173–1178.

Schweitzer B., Predki P., and Snyder M. 2003. Microarrays to characterize protein interactions on a whole-proteome scale. Proteomics 3: 2190–2199.

Tewari M., Hu P. J., Ahn J. S., Ayivi-Guedehoussou N., Vidalain P.O., Li S., Milstein S., Armstrong C.M., Boxem M., Butler M.D., et al. 2004. Systematic interactome mapping and genetic perturbation analysis of a C. elegans TGF-β signaling network. Mol. Cell 13: 469–482.

Wolfel T., Hauer M., Schneider J., Serrano M., Wolfel C., Klehmann-Hieb E., De Plaen E., Hankeln T., Meyer zum Buschenfelde K.H., and Beach D. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281–1284.

Chapter 1 References >>>